ClinicalTrials.gov record
Terminated No phase listed Observational

A Study to Understand the Genetics and Clinical Course of Focal Segmental Glomerulosclerosis (FSGS), Treatment-Resistant Minimal Change Disease (TR-MCD), and Diabetic Nephropathy (DN)

ClinicalTrials.gov ID: NCT04235621

Public ClinicalTrials.gov record NCT04235621. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 10:59 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Study to Characterize the Genetic, Biomarker, and Clinical Profile of Patients With Focal Segmental Glomerulosclerosis (FSGS), Treatment-Resistant Minimal Change Disease (TR-MCD), and Diabetic Nephropathy (DN)

Study identification

NCT ID
NCT04235621
Recruitment status
Terminated
Study type
Observational
Phase
Not listed
Lead sponsor
Goldfinch Bio, Inc.
Industry
Enrollment
20 participants

Conditions and interventions

Interventions

  • Diabetic Nephropathy (DN) Other
  • FSGS/TR-MCD Other

Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 19, 2019
Primary completion
May 26, 2020
Completion
May 26, 2020
Last update posted
Jul 19, 2021

2019 – 2020

United States locations

U.S. sites
18
U.S. states
12
U.S. cities
15
Facility City State ZIP Site status
Aventiv Research - Phoenix Mesa Arizona 85210-6041
Glendale Adventist Medical Center Glendale California 91206
DaVita Mojave Sage Dialysis Victorville California 92395-8322
Colorado Kidney Care Denver Colorado 80230-7200
Renal and Transplant Associates of New England, PC Springfield Massachusetts 01107-1369
St. Clair Nephrology Roseville Michigan 48066
DaVita Clinical Research Minneapolis Minnesota 55404-1212
Clinical Research Consultants Kansas City Missouri 64111
DaVita Pelican Point Dialysis Las Vegas Nevada 89129-6201
High Desert Nephrology Gallup New Mexico 87301-5655
Akron Nephrology Associates, Inc. Akron Ohio 44302-1715
Southeast Renal Research Institute Chattanooga Tennessee 37404-2743
Arlington Nephrology, PC Arlington Texas 76015
North Texas Kidney Disease Association Lewisville Texas 75057-6039
South Texas Renal Care Group (Downtown) San Antonio Texas 78207
San Antonio Kidney Disease Center Physicians Group (Wurzbach Road) San Antonio Texas 78229-3809
South Texas Renal Care Group (Westover Hills) San Antonio Texas 78251-1230
San Antonio Kidney Disease Center Physicians Group (Carnoustie Drive) San Antonio Texas 78258-4800

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04235621, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 19, 2021 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04235621 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →